サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561560

バイオバンキング市場レポート：検体タイプ、バイオバンクタイプ、用途、エンドユーザー、地域別、2024年～2032年

Biobanking Market Report by Specimen Type, Biobank Type, Application, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
バイオバンキング市場レポート：検体タイプ、バイオバンクタイプ、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオバンキング市場の市場規模は2023年に610億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに991億米ドルに達し、2024年から2032年の間に5.4％の成長率（CAGR）を示すと予測しています。ゲノム研究活動の増加、慢性疾患の有病率の増加、仮想バイオバンクへの注目の高まりは、市場を牽引する主な要因の一つです。

バイオバンクとは、体液や組織のサンプルを収集、保存、注釈付けし、健康や病気の理解を深める研究のために再配布するプロセスを指します。バイオバンクはサンプルの信頼できるハブであり、高品質のサンプルプールと関連データへのアクセスを可能にします。数多くの疾患の診断と医薬品製造に不可欠です。効果的なバイオマーカー同定が病気の診断と予後に不可欠である個別化医療アプローチを改善する基盤を提供します。数多くの研究や様々な調査において、提供者と研究者の仲介役を果たします。高品質な管理を行い、様々な実験の再現性の向上を支援します。また、バイオサンプルを通じて生成されたデータは、医療システムのデジタル変革に不可欠です。その結果、バイオバンクは、薬剤やバイオマーカーの開発、治療のための臨床ケア、最終的な結果に対する薬剤の効果をモニタリングする臨床試験において、世界中で広く活用されています。

バイオバンキング市場動向：

現在、ゲノム研究活動の増加によるバイオバンキング需要の高まりは、市場の成長を支える重要な要因の一つです。これに加えて、バイオバンクの数は世界中で増加しており、生物医学研究によって生成されたデータの再現性と意味を高める可能性があるため、市場の見通しは明るいです。さらに、世界中の大衆の間で、糖尿病、高血圧、がん、心臓発作、呼吸器疾患などの慢性疾患の有病率が上昇しています。このことは、病原体を効果的に同定できる診断法を開発するためのバイオバンクに対する需要の高まりと相まって、市場の成長を後押ししています。これとは別に、再生医療、個別化医療、がんゲノム研究などの先端療法への支出が増加していることも、業界の投資家に有利な成長機会を提供しています。さらに、遺伝子検査用アッセイを開発するための臨床研究施設からの生物試料の需要の増加が、市場にプラスの影響を与えています。さらに、時間的制約を最小限に抑え、高収益を上げ、研究者が円滑に調査を実施できるバーチャルバイオバンクへの注目の高まりが、市場の成長に寄与しています。さらに、主要企業は、可視性の獲得と顧客に提供するサービスの質の向上を支援するバイオバンクソフトウェアソリューションを導入しており、これが市場の成長を強化しています。

本レポートで扱う主な質問

  • 2023年の世界のバイオバンキング市場の市場規模は？
  • 2024年から2032年にかけての世界のバイオバンキング市場の予想成長率は？
  • 世界のバイオバンキング市場を牽引する主要因は何か？
  • 世界のバイオバンキング市場に対するCOVID-19の影響は？
  • 世界のバイオバンキング市場の検体タイプ別内訳は？
  • 世界のバイオバンキング市場のバイオバンクタイプ別の内訳は？
  • 世界のバイオバンキング市場の用途別の内訳は？
  • 世界のバイオバンキング市場のエンドユーザー別の内訳は？
  • バイオバンキング市場の世界における主要地域は？
  • 世界のバイオバンキング市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオバンキング市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検体タイプ別

  • 血液製品
    • 市場動向
    • 市場予測
  • 固形組織
    • 市場動向
    • 市場予測
  • 細胞株
    • 市場動向
    • 市場予測
  • 核酸
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：バイオバンクタイプ別

  • 集団ベースのバイオバンク
    • 市場動向
    • 市場予測
  • 疾患指向バイオバンク
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 治療薬
    • 市場動向
    • 市場予測
  • 調査
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 学術機関
    • 市場動向
    • 市場予測
  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Brooks Automation Inc.
    • Bay Biosciences LLC
    • Boca Biolistics
    • Ctibiotech
    • Cureline Inc.
    • Firalis
    • Greiner Bio-One International GmbH
    • Hamilton Company
    • Merck KGaA
    • ProteoGenex Inc.
    • Thermo Fisher Scientific Inc.
    • VWR Corporation（Avantor Inc.）
図表

List of Figures

  • Figure 1: Global: Biobanking Market: Major Drivers and Challenges
  • Figure 2: Global: Biobanking Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biobanking Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biobanking Market: Breakup by Specimen Type (in %), 2023
  • Figure 5: Global: Biobanking Market: Breakup by Biobank Type (in %), 2023
  • Figure 6: Global: Biobanking Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Biobanking Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Biobanking Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Biobanking (Blood Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biobanking (Blood Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biobanking (Solid Tissue) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biobanking (Solid Tissue) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biobanking (Cell Lines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biobanking (Cell Lines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biobanking (Nucleic Acid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biobanking (Nucleic Acid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biobanking (Other Specimen Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biobanking (Other Specimen Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biobanking (Population-based Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biobanking (Population-based Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Biobanking (Disease-oriented Biobanks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Biobanking (Disease-oriented Biobanks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Biobanking (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Biobanking (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Biobanking (Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Biobanking (Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Biobanking (Academic Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Biobanking (Academic Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Biobanking (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Biobanking (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia-Pacific: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia-Pacific: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Biobanking Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Biobanking Market: Breakup by Country (in %), 2023
  • Figure 79: Middle East and Africa: Biobanking Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Global: Biobanking Industry: SWOT Analysis
  • Figure 81: Global: Biobanking Industry: Value Chain Analysis
  • Figure 82: Global: Biobanking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biobanking Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biobanking Market Forecast: Breakup by Specimen Type (in Million US$), 2024-2032
  • Table 3: Global: Biobanking Market Forecast: Breakup by Biobank Type (in Million US$), 2024-2032
  • Table 4: Global: Biobanking Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Biobanking Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Biobanking Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Biobanking Market: Competitive Structure
  • Table 8: Global: Biobanking Market: Key Players
目次
Product Code: SR112024A4967

The global biobanking market size reached US$ 61.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. The rising number of genomic research activities, increasing prevalence of chronic diseases, and rising focus on virtual biobank represent some of the key factors driving the market.

Biobanking refers to the process wherein samples of bodily fluid or tissue are collected, stored, annotated, and redistributed for research to improve the understanding of health and disease. It is a reliable hub of samples and enables access to a pool of high-quality samples and associated data. It is essential for the diagnosis and production of medicines for numerous disorders. It provides a basis for improving personalized medical approaches wherein effective biomarker identification is vital for disease diagnosis and prognosis. It serves as a mediator between donor and researcher for numerous research and different studies. It has high-quality control and assists in improving the reproducibility of various experiments. It also offers data generated through biosamples that is crucial for the digital transformation of health systems. As a result, biobanking is widely utilized in drug and biomarker development, clinical care for therapy, and clinical trials monitoring for the effects of drugs on eventual outcomes across the globe.

Biobanking Market Trends:

At present, the rising demand for biobanking due to the increasing number of genomic research activities represents one of the key factors supporting the growth of the market. Besides this, the growing number of biobanks across the globe, due to its potential to enhance the reproductivity and meaning of data generated by biomedical research, is offering a positive market outlook. Additionally, there is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, cancer, heart attack, and respiratory disorders, among the masses around the world. This, coupled with the increasing demand for biobanking to develop diagnostics that can effectively identify pathogens, is propelling the growth of the market. Apart from this, the rising expenditure in advanced therapies, such as regenerative medicine, personalized medicine, and cancer genomic studies, is offering lucrative growth opportunities to industry investors. Moreover, the increasing demand for biospecimens from clinical labs to develop assays for genetic testing is positively influencing the market. In addition, the growing focus on virtual biobank that minimizes time constraints, generates high revenue, and allows researchers to conduct the research smoothly is contributing to the growth of the market. Furthermore, key players are introducing a biobank software solution that assists in gaining visibility and improving the quality of the service provided to customers, which is strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biobanking market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on specimen type, biobank type, application and end user.

Specimen Type Insights:

  • Blood Products
  • Solid Tissue
  • Cell Lines
  • Nucleic Acid
  • Others

The report has provided a detailed breakup and analysis of the biobanking market based on the specimen type. This includes blood products, solid tissue, cell lines, nucleic acid, and others. According to the report, blood products represented the largest segment.

Biobank Type Insights:

  • Population-based Biobanks
  • Disease-oriented Biobanks

A detailed breakup and analysis of the biobanking market based on the biobank type has also been provided in the report. This includes population-based biobanks and disease-oriented biobanks. According to the report, disease-oriented biobanks accounted for the largest market share.

Application Insights:

  • Therapeutics
  • Research

A detailed breakup and analysis of the biobanking market based on the application has also been provided in the report. This includes therapeutics and research. According to the report, research accounted for the largest market share.

End-User Insights:

  • Academic Institutions
  • Pharma and Biotech Companies

A detailed breakup and analysis of the biobanking market based on the end-user has also been provided in the report. This includes academic institutions and pharma and biotech companies. According to the report, academic institutions accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe was the largest market for biobanking. Some of the factors driving the Europe biobanking market included rising advancements in the stem cell and regenerative medicine research, increasing awareness about stem cell therapies, high demand for automated alarm monitoring devices, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global biobanking market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Brooks Automation Inc., Bay Biosciences LLC, Boca Biolistics, Ctibiotech, Cureline Inc., Firalis, Greiner Bio-One International GmbH, Hamilton Company, Merck KGaA, ProteoGenex Inc., Thermo Fisher Scientific Inc., VWR Corporation (Avantor Inc.), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global biobanking market in 2023?
  • 2. What is the expected growth rate of the global biobanking market during 2024-2032?
  • 3. What are the key factors driving the global biobanking market?
  • 4. What has been the impact of COVID-19 on the global biobanking market?
  • 5. What is the breakup of the global biobanking market based on the specimen type?
  • 6. What is the breakup of the global biobanking market based on the biobank type?
  • 7. What is the breakup of the global biobanking market based on the application?
  • 8. What is the breakup of the global biobanking market based on the end user?
  • 9. What are the key regions in the global biobanking market?
  • 10. Who are the key players/companies in the global biobanking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biobanking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Specimen Type

  • 6.1 Blood Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Solid Tissue
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Nucleic Acid
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Biobank Type

  • 7.1 Population-based Biobanks
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Disease-oriented Biobanks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Academic Institutions
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharma and Biotech Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Brooks Automation Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bay Biosciences LLC
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Boca Biolistics
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Ctibiotech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cureline Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Firalis
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Greiner Bio-One International GmbH
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Hamilton Company
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 ProteoGenex Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 VWR Corporation (Avantor Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio